In this study, serum indicators of diabetic nephropathy such as COMP, TM, mALB, Ang-1, Hcy, CysC and TNF-β1 were used as efficacy evaluation indicators of the clinical effect of valsartan combined with nifedipine controlled release tablets in patients with DN and hypertension. The gene discussed is COMP; the disease is liver dysplastic nodule.